Mereo BioPharma Group Q3 EPS $(0.01), Inline, Sales $800.000K
Benzinga Newsdesk 1 day ago
NewsEarnings
Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported $800.000 thousand in
Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported $800.000 thousand in sales this quarter.